 |
 |
 |
|
|
|
| April 15 (Fri.) 2022 | Online E-Conference |
| Time | Title | Chair |
| 09:00-09:30 | Registration | |
| 09:30-09:40 | Opening Remark | Mi-Kyoung Kwak (The Cathoilc University of Korea) |
| Session Ⅰ : SARS-CoV-2 Infection | ||
| 09:40~10:05 | A High-resolution Temporal Atlas of The SARS-CoV-2 Translatome and Transcriptome Daehyun Baek (Seoul National University) |
Chan Young Shin (Konkuk University) |
| 10:05~10:30 | Visualizing in Deceased COVID-19 Patients How SARS-CoV-2 Attacks The Respiratory and Olfactory Mucosae But Spares The Olfactory Bulb Seung-Jun Yoo (Hanyang University) |
|
| 10:30~10:55 | How SARS-CoV-2 First Adapted in Humans Hyeryun Choe (The Scripps Research Institute) |
|
| 10:55~11:15 | Intermediate Break | |
| Session Ⅱ : Strategy for COVID-19 Prevention and Treatment | ||
| 11:15~11:40 | Causality Assessment of Covid-19 Vaccines and Adverse Events and Their Limitation JaeHun Jung (Gachon University) |
Yi-Sook Jung (Ajou University) |
| 11:40~12:05 | Two Examples of RNA-based Drugs in Use Are mRNA Vaccines and RNA Adjuvants Jae-Hwan Nam (The Catholic University of Korea) |
|
| 12:05-12:30 | The Use of Non-human Primate Model for Infectious Disease Jung Joo Hong (Korea Research Institute of Bioscience and Biotechnology) |
|
| 12:30~14:00 | Lunch | |
| Session Ⅲ : Discovery of Novel Therapeutic Agents for COVID-19 Treatment-1 | ||
| 14:00-14:25 | Collaborative Efforts for COVID-19 Drug Development Seungtaek Kim (Institute Pasteur Korea) |
Choong Jae Lee (Chungnam National University) |
| 14:25-14:50 | Identification of Novel Protease Inhibitors of SARS-CoV-2 Wonsik Lee (Sungkyunkwan University) |
|
| 14:50-15:15 | Advances in COVID-19 treatment Man-Seong Park (Korea University) |
|
| 15:15~15:30 | Intermediate Break | |
| Session Ⅳ : Discovery of Novel Therapeutic Agents for COVID-19 Treatment-2 | ||
| 15:30~15:55 | Senescence Is Identified As A Driver and Therapy Target of COVID-19 Disease Soyoung Lee (Charite-Berlin University & Johannes Kepler University Linz) |
Sun-Young Han (Gyeongsang National University) |
| 15:55~16:20 | Development of COVID-19 Treatment and Immune Adjuvant Drugs from Natural Products Se Chan Kang (Kyung Hee University) |
|
| 16:20~16:45 | Artificial Intelligence to Accelerate Drug Development: A Case Study Keunsoo Kang (Dankook University) |
|
| 16:45 | Closing Remark |
|
